South Dakota 2023 Regular Session

South Dakota House Bill HB1154

Introduced
1/26/23  
Refer
1/26/23  
Report Pass
2/9/23  
Engrossed
2/13/23  
Refer
2/14/23  
Report Pass
2/27/23  
Enrolled
3/1/23  

Caption

Modify acceptable conduct for practitioners related to medical cannabis.

Impact

The introduction of HB 1154 is expected to impact state laws governing medical cannabis by establishing stricter guidelines for practitioner conduct. It addresses ethical concerns related to financial conflicts of interest that may arise in the certification process for medical cannabis patients. By imposing these restrictions, the bill seeks to ensure that practitioners prioritize their patients' health and well-being over profit motives, thereby fostering greater trust in the healthcare system surrounding medical cannabis.

Summary

House Bill 1154 aims to modify and clarify acceptable conduct for practitioners related to medical cannabis in South Dakota. The bill introduces specific prohibitions against practitioners engaging in financial transactions with patients or entities related to medical cannabis. These regulations include barring practitioners from referring patients for financial gain, advertising in cannabis establishments, and charging fees based on the duration of written certifications. This legislation intends to uphold ethical standards within the practitioner-patient relationship in the context of medical cannabis treatment.

Sentiment

The sentiment surrounding House Bill 1154 is generally positive among proponents who argue that it is a necessary step for protecting patients and maintaining integrity within the medical community. Supporters believe that these regulations will help to prevent exploitation and ensure that medical cannabis is accessed in an ethical manner. However, there may be concerns raised by some practitioners who feel that the restrictions could limit their ability to effectively engage with patients regarding medical cannabis.

Contention

Notable points of contention regarding HB 1154 may include the potential pushback from practitioners who perceive the bill as overly restrictive and infringing on their professional autonomy. Critics may argue that the regulations could hinder communication and the development of practitioner-patient relationships if doctors are not permitted to incentivize patient appointments. Balancing the need for ethical practice with practitioner flexibility will likely be a point of debate as the bill progresses.

Companion Bills

No companion bills found.

Previously Filed As

SD SB5

Revise acceptable conduct related to the medical use of cannabis.

SD HB1055

Modify medical cannabis certification requirements.

SD SB82

Modify standards for a bona fide practitioner-patient relationship required prior to the issuance of a medical cannabis certification.

SD SB1

Modify debilitating medical conditions for medical cannabis use.

SD SB42

Modify provisions related to medical cannabis.

SD HB1129

Modify and establish provisions related to medical cannabis.

SD SB26

Revise the definition of practitioner for purposes of the medical cannabis program.

SD HB1102

Clarify and modify requirements related to the medical cannabis program.

SD SB11

Prohibit a practitioner from referring a patient to a medical cannabis clinic with which the practitioner or an immediate family member has a financial relationship and to provide a penalty therefor.

SD HB1097

Clarify conduct that is not required related to medical cannabis.

Similar Bills

No similar bills found.